Coronary Disease 
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Coronary Disease
OCTandCAV, NCT02254668: Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography

Recruiting
4
278
Europe
Protocol with Everolimus (Certican®), Randomizaiton by SecuTrial, Protocol with Mycophenolate mofetil (CellCept®)
University of Zurich, Novartis Pharmaceuticals
Intimal Proliferation, Immunosuppression
02/23
02/23
FANTOM II, NCT02539966: Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

Active, not recruiting
N/A
220
Europe, RoW
Fantom Sirolimus-Eluting Coronary Bioresorbable Scaffold
REVA Medical, Inc.
Coronary Artery Disease
08/19
09/24
FUTURE-II, NCT02890160: A Trial of Firesorb in Patients With Coronary Artery Disease:

Active, not recruiting
N/A
430
RoW
Firesorb, XIENCE
Shanghai MicroPort Medical (Group) Co., Ltd.
Coronary Artery Disease
10/20
10/24
Arineta, NCT02616939: Clinical In-hospital Evaluation of the Usefulness of a New Multi-detector Computed Tomography Scanner From Ltd

Recruiting
N/A
400
RoW
Cardiac CT scanning (with the SpotLight CT)
Carmel Medical Center, Arineta Ltd.
Coronary Artery Disease
11/20
11/22

Download Options